Pioneering Drug Discovery
Transforming Scientific
Breakthroughs into
Innovative Medicines
AxionThera Therapeutics is a portfolio biopharmaceutical company translating breakthroughs in biology and basic medical research into innovative new medicines.
20+
Active Therapeutic Programs
6
Programs in Development
2016
Founded
2
UK & USA Operations
Our Mission
We translate breakthroughs in biology and basic medical research into innovative new medicines. With over 20 active therapeutic programs, we are building a large, diversified portfolio of novel therapeutics with uncorrelated risk.
Our central premise since our inception in 2016 is that breakthroughs in the basic medical research required to create innovative new medicines are best found in the world's top universities.
Founded in partnership with world-leading institutions
We believe that the most transformative medicines begin with bold science and world-class partnerships. Our mission is to turn the promise of academic research into real treatments for patients who need them most.
Dr. Terry Spencer
Founder & Chief Executive Officer